The potential for targeting the STAT3 pathway as a novel therapy for melanoma.
about
Other targeted drugs in melanomaInhibition of Jak/STAT signaling reduces the activation of pancreatic stellate cells in vitro and limits caerulein-induced chronic pancreatitis in vivo.Renalase Expression by Melanoma and Tumor-Associated Macrophages Promotes Tumor Growth through a STAT3-Mediated MechanismSTAT3 activation in infection and infection-associated cancer.Patient with confirmed LEOPARD syndrome developing multiple melanoma.Macrophages in skin melanoma-the key element in melanomagenesis.
P2860
The potential for targeting the STAT3 pathway as a novel therapy for melanoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
The potential for targeting the STAT3 pathway as a novel therapy for melanoma.
@en
The potential for targeting the STAT3 pathway as a novel therapy for melanoma.
@nl
type
label
The potential for targeting the STAT3 pathway as a novel therapy for melanoma.
@en
The potential for targeting the STAT3 pathway as a novel therapy for melanoma.
@nl
prefLabel
The potential for targeting the STAT3 pathway as a novel therapy for melanoma.
@en
The potential for targeting the STAT3 pathway as a novel therapy for melanoma.
@nl
P2860
P356
P1433
P1476
The potential for targeting the STAT3 pathway as a novel therapy for melanoma.
@en
P2093
Gregory B Lesinski
P2860
P304
P356
10.2217/FON.13.83
P407
P577
2013-07-01T00:00:00Z